What is CTIC's gross margin?

CTI BioPharma (CTIC) has a gross margin of 95% and a net margin of -90%.

What is CTIC's P/E ratio?

Track CTI BioPharma (CTIC) P/E ratio, ROE, and valuation metrics over time.

Where can I see CTIC's full financials?

See CTI BioPharma (CTIC) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

CTI BioPharma (CTIC) Financials — Revenue, Earnings, Cash Flow

$9.10

Last traded 2023-06-23 — delisted

NASDAQ · Healthcare · Biotechnology · $1.2B mcap · 100M float · 6.36% daily turnover

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$76M

Revenue

+3201.5% YoY

$-77M

Net Income

+35.4% YoY

$-82M

Free Cash Flow

+16.1% YoY

94.9%

Gross Margin

-38.3%

Op. Margin

-90.4%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE289.2%

ROA-63.2%

ROIC120.1%

Valuation

P/E-11.5

P/B-59.3

EV/EBITDA-10.7

Leverage

Debt/Equity-1.93

Current Ratio1.27

Interest Cov.-3.1x

Quality Scores

Piotroski F4/9

Altman Z-29.84

Beneish M6.23